BIOMÉRIEUX ● The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
● In a short-term perspective, the company has interesting fundamentals.
Strengths
● Graphically speaking, the timing seems perfect for purchasing the stock close to the EUR 110.9 support.
● The company is in a robust financial situation considering its net cash and margin position.
● The group usually releases upbeat results with huge surprise rates.
● Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
● Over the last twelve months, the sales forecast has been frequently revised upwards.
● For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
● For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
● The tendency within the weekly time frame is positive above the technical support level at 102 EUR
Weaknesses
● With an enterprise value anticipated at 4.36 times the sales for the current fiscal year, the company turns out to be overvalued.
● The firm trades with high earnings multiples: 36.63 times its 2020 earnings per share.
● The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
